Assura (LON:AGR – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Berenberg Bank in a report released on Tuesday, Digital Look reports. They currently have a GBX 51 ($0.67) target price on the real estate investment trust’s stock. Berenberg Bank’s target price indicates a potential upside of 21.26% from the company’s previous close.
Separately, Shore Capital reissued a “hold” rating on shares of Assura in a report on Tuesday, August 13th.
View Our Latest Stock Report on AGR
Assura Trading Up 0.5 %
Insider Transactions at Assura
In related news, insider Jonathan Murphy sold 223,534 shares of the business’s stock in a transaction dated Wednesday, July 10th. The stock was sold at an average price of GBX 42 ($0.55), for a total value of £93,884.28 ($124,021.51). 8.38% of the stock is currently owned by insiders.
Assura Company Profile
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK – caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.
Read More
- Five stocks we like better than Assura
- What is the FTSE 100 index?
- Trucking Stocks Rebound: Big Rigs, Bigger Opportunity
- Options Trading – Understanding Strike Price
- Johnson Controls: AI Sleeper Stock Set to Cool Data Centers
- Why Are Stock Sectors Important to Successful Investing?
- Maximize Gains: Invest in AST SpaceMobile’s 5G Breakthrough
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.